funder-graph

FundersCT

Grants paid by The Foundation for a Cure for Mitochondrial Disease Inc

EIN 06-1602020 · Cheshire, CT · Form 990, Schedule I · NTEE H20

The Foundation for a Cure for Mitochondrial Disease Inc of Cheshire, CT (EIN 06-1602020) reported 11 grants paid totaling $1,006,130 to 4 recipients in tax years 2018–2024, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.

Grants paid

$1,006,130

11 grants

Recipients

4

distinct organizations

Tax years

2018–2024

7 filings in the corpus

By tax year

Grants by tax year, as the same figures
Tax yearGrants paidAmount paidApproved for future
20183$280,000
20191$75,000
20201$75,000
20211$75,000
20221$75,000
20231$75,000
20243$351,130

Top recipients

The 4 recipients receiving the most from The Foundation for a Cure for Mitochondrial Disease Inc, by grants paid, out of 4 distinct recipients.

Recipients ranked by total grants paid
RecipientMatchLocationGrantsTotal paidLatest year
Pheno Matrix Inc 04-3491968ABoston, MA7$525,0002024
Massachusetts Eye and Ear Infirmary 04-2103591ABoston, MA2$350,0002024
The Research Fund for Suny 14-1368361AAlbany, NY1$101,1302024
Columbia University 13-5598093ANew York, NY1$30,0002018

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Every grant

All 11 grant rows this organization reported, most recent first.

Grants reported by The Foundation for a Cure for Mitochondrial Disease Inc
Tax yearRecipientMatchAmountTypePurposeSource filing
2024Meei Research Boston, MAA$175,000paidMEDICAL RESEARCH202512519349301326
2024The Research Fund for Suny Albany, NYA$101,130paidMEDICAL RESEARCH202512519349301326
2024Pheno Matrix Inc Boston, MAA$75,000paidMEDICAL RESEARCH202512519349301326
2023Pheno Matrix Inc Boston, MAA$75,000paidMEDICAL RESEARCH202421979349300512
2022Pheno Matrix Inc Boston, MAA$75,000paidMEDICAL RESEARCH202343059349302309
2021Pheno Matrix Inc Boston, MAA$75,000paidMEDICAL RESEARCH202222089349300642
2020Pheno Matrix Inc Boston, MAA$75,000paidMEDICAL RESEARCH202122159349300102
2019Pheno Matrix Inc Boston, MAA$75,000paidMEDICAL RESEARCH202042199349300019
2018Massachusetts Eye and Ear Infirmary Boston, MAA$175,000paidMEDICAL RESEARCH201912129349301501
2018Pheno Matrix Inc Boston, MAA$75,000paidMEDICAL RESEARCH201912129349301501
2018Columbia University New York, NYA$30,000paidMEDICAL RESEARCH201912129349301501

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Source filings

Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.

Returns this page is derived from
FormTax yearPeriod endFiledSchemaIRS OBJECT_ID
99020242024-12-31not stated2024v5.0202512519349301326
99020232023-12-31not stated2023v5.0202421979349300512
99020222022-12-31not stated2022v5.0202343059349302309
99020212021-12-31not stated2021v4.0202222089349300642
99020202020-12-31not stated2020v4.0202122159349300102
99020192019-12-31not stated2019v5.0202042199349300019
99020182018-12-31not stated2018v3.1201912129349301501

Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/061602020.json.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.